Skip to content
value.today
Novonix Ltd logo

Novonix Ltd

NVX
$110 Mmarket cap on Aug 1, 2026
#18,392 in the world#435 in 🇦🇺 Australia
Compare
World rank
#18,392
Revenue
$6 M
For year ending December-2025
Net income
$-93 M
-1650.0% margin
SEC filing
Employees
—

Novonix Ltd in brief

Novonix Ltd is a listed company, based in Australia. Its market value was $110 M on 1 August 2026, which makes it the 18,392nd largest listed company in the world and the 435th largest in Australia on this site. In the year to December 2025 it had sales of $6 M and a net loss of $93 M. Michael O'Kronley is its chief executive. Its shares trade under the symbol NVX (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Novonix Ltd timeline

2 events, 2015–2021
  1. 2015
  2. 🔔
    Initial public offering on Australian Securities Exchange as NVX
  3. 2021
  4. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.

Events of Novonix Ltd from Wikidata and SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

Not enough history yet.

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
19.6×
Price / book
0.7×
Free cash flow yield
-93.1%
Net margin (TTM)
-1650.0%
Operating margin
4913.5%
Return on equity
-57.4%
Liabilities / assets
42.9%
Net debt
$-48M
Revenue growth
-3.9%
R&D / revenue
100.9%

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Jun 2020: revenue $3M, net income $-13M$3MFY20Fiscal year ending Jun 2021: revenue $4M, net income $-13M$4MFY21Fiscal year ending Jun 2022: revenue $6M, net income $-52M$6MFY22Fiscal year ending Dec 2023: revenue $8M, net income $-46M$8MFY23Fiscal year ending Dec 2024: revenue $6M, net income $-75M$6MFY24Fiscal year ending Dec 2025: revenue $6M, net income $-93M$6MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$6M-3.9%$276M$-93M-1650.0%
Dec 2024$6M-27.3%$151M$-75M-1279.0%
Dec 2023$8M+32.0%—$-46M-574.5%
Jun 2022$6M+56.4%—$-52M-850.2%
Jun 2021$4M+36.8%—$-13M-345.6%
Jun 2020$3M——$-13M-471.2%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-42M$60M$-102M$-0.14—
Dec 2024$-40M$30M$-70M$-0.15—
Dec 2023$-36M$19M$-55M$-0.09—
Jun 2022$-29M$84M$-113M$-0.11—
Jun 2021$-6M$20M$-26M$-0.04—
Jun 2020$-4M$4M$-7M$-0.10—

SEC filings

Official filings of Novonix Ltd with the US Securities and Exchange Commission.

Annual results

Revenue
$6 M
Operating income
$276 M
Net income
$-93 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$283 M
Total liabilities
$121 M
Total equity
$162 M

As of December-2025

Top 18 institutional investors in Novonix Ltd#

As of Sep 30, 2026
18 institutions held 325,314 shares on Sep 30, 2026. Source: SEC Form 13F filings, filed through Nov 16, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 18 largest institutional investors in Novonix Ltd
#InstitutionShares heldChange (shares)ValueFiled
1UBS Group AG127,197New$0 MNov 10, 2026
2Forest Avenue Capital Management LP118,812New$0 MNov 13, 2026
3Goldman Sachs Group Inc22,972New$0 MNov 16, 2026
4Jane Street Group, LLC12,031New$0 MNov 12, 2026
5Citadel Advisors LLC11,454New$0 MNov 16, 2026
6XY Capital Ltd10,808New$0 MNov 13, 2026
7Bank Of America Corp /de/10,190New$0 MNov 16, 2026
8Morgan Stanley6,358New$0 MNov 13, 2026
9Jpmorgan Chase & Co1,697New$0 MNov 12, 2026
10GK Wealth Management LLC1,527New$0 MOct 9, 2026
11Tower Research Capital LLC (TRC)1,043New$0 MNov 16, 2026
12Wells Fargo & Company/mn395New$0 MNov 16, 2026
13Simplex Trading, LLC321New$0 MNov 4, 2026
14Osaic Holdings, Inc.182New$0 MNov 12, 2026
15Jones Financial Companies Lllp136New$0 MNov 13, 2026
16Royal Bank Of Canada97New$0 MNov 16, 2026
17GAMMA Investing LLC68New$0 MOct 8, 2026
18Rhumbline Advisers26New$0 MNov 10, 2026

Mutual funds holding Novonix Ltd#

15 funds in 2 countries hold shares worth $2 M (about 1.9% of the company). Since their previous reports 4 added shares and 5 sold, selling $1 M net. By country: USA 14 ($2 M), Sweden 1 ($0 M).
Mutual funds holding Novonix Ltd
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total International Stock Index FundThe Vanguard Group, Inc.9.43 M$1 M0.87%<0.01%−7.8%Jul 31, 2026
🇺🇸 Vanguard Developed Markets Index FundThe Vanguard Group, Inc.6.63 M$1 M0.61%<0.01%no changeJun 30, 2026
🇺🇸 Schwab International Small-Cap Equity ETFCharles Schwab Investment Management, Inc.1.48 M$0 M0.14%<0.01%+4.8%May 31, 2026
🇸🇪 Storebrand Global PlusStorebrand Asset Management AS1.74 M$0 M0.16%0%−2.3%Jun 30, 2026
🇺🇸 Vanguard Pacific Stock Index FundThe Vanguard Group, Inc.850,471$0 M0.08%<0.01%−4.1%Jul 31, 2026
🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc.445,314$0 M0.04%<0.01%−2.5%Jul 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC26,408$0 M—<0.01%+399%May 31, 2026
🇺🇸 Vanguard Esg International Stock ETFThe Vanguard Group, Inc.94,513$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 State Street SPDR S&P International Small Cap ETFSSGA Funds Management, Inc.142,698$0 M0.01%<0.01%+1.0%Jun 30, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP129,576$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 Avantis International Small Cap Equity ETFAmerican Century ETF Trust33,639$0 M<0.01%<0.01%+18%May 31, 2026
🇺🇸 Dimensional VA International Small PortfolioDimensional Fund Advisors LP30,011$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 AZL DFA International Core Equity FundAllianz Investment Management LLC24,877$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 International Small Company TrustJohn Hancock Variable Trust Advisers LLC11,595$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 LVIP Dimensional International Core Equity FundLincoln Financial Investments Corporation3,822$0 M<0.01%<0.01%no changeJun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 15 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Novonix Ltd#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$0
open market only
Insiders on file
2
since
Novonix Ltd: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Sharan BurrowDirectorOther+31,250$0.160$5 K246,989Form 4
filed Robert J. NatterDirectorOther-230,343——0Form 4
filed Robert J. NatterDirectorOtherindirect+81,606——1.45 MForm 4
filed Robert J. NatterDirectorOtherindirect+148,737——1.45 MForm 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Novonix Ltd#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
415,427
20.08 days to cover
Shares sold short, last 24 reportsAll stocks →

Trading halts

  • 2026-08-26 23:50 UTC, code T3, resumed 13:00 UTC
  • 2026-06-15 23:30 UTC, code T3, resumed 11:00 UTC
  • 2024-11-25 22:53 UTC, code T3, resumed 23:35 UTC

Fails to deliver

  • : 73 shares at $2.46
  • : 86 shares at $2.11
  • : 896 shares at $2.12
  • : 1,949 shares at $2.11
  • : 2,618 shares at $2.16

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Novonix Ltd scorecard#

Passes 2 of the 11 checks that could be worked out: strongest in financial health (2 of 3), weakest in growth (0 of 5). Fiscal year 2025; market cap of Aug 1, 2026.

  • Valuationnot known
    • –P/E below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Price to book below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Price to sales below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Free cash flow yield above 5%The market cap dates from 2026-08-01, more than 60 days ago.
    • –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-08-01, more than 60 days ago.
    • –The price assumes slower growth than the last three years'The market cap dates from 2026-08-01, more than 60 days ago.
  • Growth0 of 5
    • ✗Revenue grew in the newest year-3.9%Revenue down 3.9% in fiscal 2025.
    • ✗Revenue up more than 5% a year over three years-2.7%-2.7% a year over the three years to fiscal 2025.
    • –Faster growth over three years than its peers' medianToo few peers for a median.
    • ✗Earnings per share grew in the newest year-0.14 vs -0.15Diluted EPS -0.14 in fiscal 2025 against -0.15 the year before (report's currency).
    • ✗Net income higher than five years earlier-$93 M-$93 M in fiscal 2025 against -$13 M in 2020.
    • ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2025.
  • Profitability0 of 3
    • ✗Profitable in the newest year-$93 MNet income -$93 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • –Operating margin above its peers' medianNo operating margin on file.
    • ✗Return on equity above 15%-62.0%-62.0% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health2 of 3
    • –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
    • ✓Debt below equity0.2×Debt to equity 0.20 at the end of fiscal 2025.
    • ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $48 M at the end of fiscal 2025.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Novonix Ltd's statements.

Novonix Ltd: main financial ratios in 2025
Ratio2025
Return on equity-62.0%
Revenue growth, 3 years a year-2.7%
Revenue growth-3.9%
Debt to equity0.20×

3of 7on the Piotroski tests of financial strength

  • Revenue fell 3.9% against the year before.
  • Net loss of $93 million, the 6th loss-making year in a row.
  • Free cash flow was negative: -$102 million.
  • More cash than debt: net cash of $48 million.

Novonix Ltd: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in millions of each column's currency; per-share figures in the column's currency; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Novonix Ltd: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025 · USDFY 2024to Dec 31, 2024 · USDFY 2023to Dec 31, 2023 · USDFY 2022to Jun 30, 2022 · USDFY 2021to Jun 30, 2021 · AUDFY 2020to Jun 30, 2020 · USD
Income statement
Revenue5.65.98.16.15.22.9
Research and development5.74.85.85.12.81.6
Operating income276151————
Interest and finance income1.11.41.60.00.00.0
Income before tax−93−75−46−52−18−13
Income tax0.00.1−0.2000
Income from continuing operations−93−75−46−52−18—
Net income including minority interests−93−75−46−52−18−13
Net income attributable to shareholders−93−75−46−52−18−13
Earnings per share, basic-0.14-0.15-0.09-0.11-0.05-0.10
Earnings per share, diluted-0.14-0.15-0.09-0.11-0.05-0.10
Shares, weighted average (basic)682497487464366136
Shares, weighted average (diluted)682497487464366136
Balance sheet
Cash and cash equivalents80437914313727
Receivables2.18.23.62.52.00.7
Inventory2.21.42.01.92.80.9
Current assets89578916214428
Property, plant and equipment175149140104326.6
Right-of-use (leased) assets5.76.44.55.17.42.0
Goodwill121212121612
Non-current assets1941691741415923
Total assets28322626330320352
Accounts payable138.55.86.54.42.5
Current liabilities844637r7.95.44.0
Long-term debt323335r366.01.3
Lease liabilities (non-current)5.96.54.55.07.11.9
Non-current liabilities384242r44133.2
Total liabilities121897952187.2
Retained earnings−352−260−185−111−82−45
Total equity16213818425118445
Cash-flow statement
Depreciation and amortization4.64.64.74.21.71.2
Share-based compensation−1.15.55.6155.95.1
Cash from operating activities−42−40−36−29−8.2−3.7
Capital expenditure−60−30−19−84−26−3.6
Intangible assets bought———−0.0——
Cash from investing activities−33−18−12−107−26−3.7
Debt issued——0.8334.14.4
Debt repaid−1.3−1.4−1.1−0.6−0.1−4.7
Shares issued25290.315113732
Cash from financing activities110252918113330
Exchange-rate effect on cash2.5−2.8−1.7−4.5−0.2−0.6
Report20-F20-F20-F20-F20-F20-F

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Dec 31, 2025. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Aug 1, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, Wikidata; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Novonix Ltd? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Novonix Ltd's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Novonix Ltd? Suggest a correction